https://pro.campus.sanofi/us/products/cablivi
CABLIVI (caplacizumab-yhdp) for Adults with aTTP/iTTP
CABLIVI (caplacizumab-yhdp) is indicated to treat adults with acquired/immune-mediated thrombotic thrombocytopenic purpura (aTTP/iTTP) in combination with...
yhdpadultsattpittp
https://tpch.net/fy25nofo/
TPCH Local Competition Headquarters for FY25 C0C YHDP funds
Dec 1, 2025 - Review and submit a local application for the FY 2025 Continuum of Care and Youth Homeless Demonstration Program Grants NOFO.
tpchlocalcompetitionyhdpfunds